Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Milestone Pharmaceuticals Inc. Common Shares, no par value (MIST).
- Disclosed ownership: 0.6%.
- Date of event: 31 Mar 2025.
INTEGRATED CORE STRATEGIES (US) LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Milestone Pharmaceuticals Inc. Common Shares, no par value (MIST)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Integrated Core Strategies (US) LLC
- Symbol
- MIST
- Shares outstanding
- 53,680,333 shares
- Disclosed Ownership
- 322,082 shares
- Ownership
- 0.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Apr 2025, 16:00:20 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 0.6% ownership in Milestone Pharmaceuticals Inc. Common Shares, no par value (MIST) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Apr 2025, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 0.6% | 322,082 | 0 | 322,082 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 0.6% | 322,082 | 0 | 322,082 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 0.6% | 322,082 | 0 | 322,082 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 0.6% | 322,082 | 0 | 322,082 | /s/ Israel A. Englander | Israel A. Englander |